PHGE
Biomx Inc
NYSE MKT: PHGE · HEALTHCARE · BIOTECHNOLOGY
$0.85
+34.07% today
Updated 2026-04-30
Market cap
$7.54M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-37.05
Dividend yield
—
52W range
$1 – $14
Volume
0.2M
Biomx Inc (PHGE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $13.99M | $45.33M | $92.12M | $70.36M | $77.99M | $45.53M | $25.03M | $43.23M |
| Cash & equivalents | $6.99M | $8.60M | $72.41M | $36.48M | $62.10M | $31.33M | $14.91M | $17.81M |
| Current assets | $8.47M | $39.89M | $84.53M | $60.67M | $66.64M | $36.88M | $17.63M | $20.52M |
| Total liabilities | $2.46M | $2.53M | $7.67M | $12.89M | $30.45M | $24.49M | $21.95M | $19.09M |
| Current liabilities | $1.46M | $1.64M | $6.22M | $7.16M | $11.04M | $7.94M | $11.18M | $8.27M |
| Long-term debt | — | $500000.00 | — | — | $14.41M | $10.59M | $5.40M | — |
| Shareholder equity | $11.53M | $42.80M | $84.46M | $57.47M | $47.53M | $21.04M | $3.08M | $24.15M |
| Retained earnings | $-8.89M | $-21.61M | $-42.17M | $-72.26M | $-108.48M | $-136.80M | $-162.97M | $-180.70M |
| Accounts receivable | $327000.00 | $129000.00 | $244000.00 | $276000.00 | $888000.00 | $567000.00 | $574000.00 | $1.17M |
| Inventory | — | $-29000.00 | $1.98M | — | $108000.00 | $395000.00 | — | $-958000.00 |
| Goodwill | — | — | — | — | — | — | — | — |